Clinical trials: Patients Presenting With Suspicion of Infection to the ED
Viral Infection, Bacterial Infections
A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection
To externally validate the diagnostic accuracy and assess the clinical utility of a host-response based diagnostic tool called ImmunoXpert™, for differentiating between bacterial and viral etiologies in pediatric patients >3…
- Conditions
- Viral Infection, Bacterial Infections, Antibiotic Misuse, Host Response Diagnostics
- Trial name
- ROSETTA (NCT04254991)
- Testing
- ImmunoXpert™
- Volunteers
- 525 people
- Sponsor
- MeMed Diagnostics Ltd.
Sepsis
Prospective Observational Study to Compare REMS vs NEWS2 for Patients Presenting to the ED With Sepsis
Prospective observational study to determine the utility of Rapid Emergency Medicine Score (REMS) in comparison to National Early Warning Score2 (NEWS2) for predicting morbidity and mortality among patients presenting to the…
- Trial name
- NCT07171918
- Testing
- Antibiotics, Vasopressors
- Where
- India
- Volunteers
- 130 people
- Sponsor
- Jubilee Mission Medical College and Research Institute
Patients Presenting With Suspicion of Infection to the ED
Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as…
- Trial name
- IDEAL (NCT03770533)
- Testing
- MR-proADM guided
- Where
- 4 sites in Spain
- Volunteers
- 200 people
- Sponsor
- Brahms AG
Patients Presenting With Suspicion of Infection to the ED
Risk Stratification Using Midregional Proadrenomedullin in the ED
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as…
- Trial name
- NCT05108883
- Testing
- MR-proADM KRYPTOR
- Where
- 9 sites in France, Italy and 2 more
- Volunteers
- 463 people
- Sponsor
- Brahms AG